JP Morgan Breaks the Bearish Trend on SKYD

JP Morgan upgraded SKYD to Neutral with a $9 target on Thursday, the first constructive move from any major firm after weeks of cuts. The stock has recovered to $7.79, up 7.3% over the past week, even as its closest peers fell a median 4.6%.

Analysts Were Moving One Way

The previous three analyst actions on Skydance Corporation were all negative. Bernstein halved its target from $12 to $6 on October 16, keeping an Underperform. StoneX cut from $16 to $11 on October 12, holding a Buy. Barclays trimmed from $8 to $7 on October 7, maintaining Underweight.

JP Morgan's David Karnovsky moved against that current Thursday, upgrading from Underweight to Neutral and announcing a $9 target. The mean price target across the panel now sits at $8.87, above the current close of $7.79.

The bull case rests on the merged entity's $6 billion-plus cost synergy target, DTC profitability at $251 million adjusted EBITDA, and a content strategy that saw Studios EBITDA double and TV Media margins expand to 29% in the most recent quarter.

The bear case is not resolved. Pro forma net debt stands at $79 billion. The path to roughly 3x leverage depends on synergy delivery. The theatrical commitment of 30 films annually in years one and two carries $30 million per-film penalties for misses.

Short Positioning Remains Heavy

Short interest climbed 69% over the past month to roughly 130 million shares. The lending market tightened sharply during this period. Availability dropped to a 52-week low of 19.4% on October 15, meaning fewer than one share remained available to borrow for every five already out on loan. It has since recovered to 39.2%, but that still represents a tight market.

Cost to borrow peaked above 3.3% mid-October and has since eased to 2.2%. The ORTEX short score has fallen from above 77 a week ago to 58.9, a meaningful shift in the short-side pressure reading.

The put-to-call ratio dropped sharply to 0.42 on Wednesday, well below its 20-day mean of 0.83 and at a z-score of -1.65. Call volume is running well above recent norms.

Wikipedia page views for the company registered a retail attention z-score of 3.6 against its own 90-day history as of October 13, a measure of unusual public interest, not a revenue signal.

Key Data Points

• JP Morgan upgrade: Underweight to Neutral, $9 target, October 23
• Bernstein: target cut from $12 to $6, Underperform maintained, October 16
• Mean analyst target: $8.87; current close: $7.79
• Shares short: approximately 130 million, up 69% over one month
• Borrow availability: 39.2% (52-week low was 19.4% on October 15)
• Cost to borrow: 2.2%, down from a peak above 3.3% mid-October
• ORTEX short score: 58.9, down from 77.7 one week ago
• Put-to-call ratio: 0.42, z-score of -1.65 versus the 20-day mean
• Earnings scheduled: November 4